Real-World Japanese Study of the Effectiveness and Safety of Switching From Dupilumab to Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis
用户lCrXlT2ANPjQ
1个月前
82
10
已完结
1. 系统已在2026-04-02 15:40:30对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://www.liebertpub.com/doi/10.1089/derm.2025.0046
其他信息:
出版社: SAGE Publications
作者: Teppei Hagino; Akihiko Uchiyama; Marina Onda; Keiji Kosaka; Takeshi Araki; Sei-ichiro Motegi; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
